LabStyle Innovation Signs Agreement with uHealth to Exclusively Distribute the Dario™ Blood Glucose Monitoring Device in Australia
CAESAREA, Israel, Feb. 4, 2014 /PRNewswire/ — LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ Diabetes Management Platform, announced today that the company has signed … Read more
LabStyle President and CEO Erez Raphael to Present and Demonstrate Dario™ at the Biotech Showcase 2014 in San Francisco, January 13, 2014 at 8:30 a.m.
A replay of LabStyle president and CEO Erez Raphael’s Biotech Showcase presentation from January 13, 2014 can be accessed here through February … Read more
LabStyle Innovations Files 510(k) in the U.S. for FDA Clearance of the Dario™ Blood Glucose Monitoring System
CAESAREA, Israel, Jan. 7, 2014 /PRNewswire/ — LabStyle Innovations Corp. (OTCQB:DRIO), developer of Dario™, a cloud-based, mobile health platform for diabetes and blood … Read more